Drug intelligence / Profile preview

cinnamomum cassia extract

Development stage
Unknown
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

*Cinnamomum cassia extract* is a botanical extract derived from the bark of the Cinnamomum cassia tree, commonly called Chinese cinnamon. It consists primarily of phenylpropanoids, with **cinnamaldehyde** as the major bioactive compound, often representing 60–80% of the volatile content depending on the extraction method. Other key constituents include coumarin, cinnamic acid, cinnamyl acetate, 2-methoxycinnamaldehyde, and eugenol. **Mechanism of action:** - Exhibits **antimicrobial effects**: C. cassia extract shows in vitro activity against multiple bacteria and fungi, attributed mainly to cinnamaldehyde, which disrupts microbial cell structure or metabolism[4][5]. - Demonstrates **anti-inflammatory activity**: The extract, particularly 2'-hydroxycinnamaldehyde, inhibits nitric oxide production and nuclear factor kappa-B (NF-κB) activation in inflammatory pathways[1][4]. - Shows **antioxidant effects**: The moderate content of phenolic compounds contributes to scavenging of free radicals and reduction of oxidative stress[1][5]. - **Other pharmacological actions**: Animal and in vitro studies suggest possible anti-diabetic, hypotensive, vasodilatory, and neuroprotective properties, largely via effects on enzymes like cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and modulation of calcium signaling in vascular smooth muscle[1][5]. Cinnamomum cassia extract is primarily marketed as a **dietary supplement** for general health, blood sugar control, antioxidant support, and food preservation, not as a pharmaceutical drug[6].

Other names
cassia extractchinese cinnamon extractcassia bark extractCinnamomum aromaticum extract
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)STAT3 (Signal Transducer and Activator of Transcription 3)NF-κBNOS2 (Nitric Oxide Synthase 2)

Beyond the preview

Go deeper on cinnamomum cassia extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cinnamomum cassia extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call